BNTC icon

Benitec Biopharma
BNTC

Overview Fund Activity

5 hedge funds and large institutions have $1.05M invested in Benitec Biopharma in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
2
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$971K
2
VF
2
Virtu Financial
New York
$8K
3
Morgan Stanley
3
Morgan Stanley
New York
$56K
4
UBS Group
4
UBS Group
Switzerland
$4K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
SFM
2
Sphera Funds Management
Israel
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
OMC
4
Old Mission Capital
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$971K 1,365,615 +1,365,615 New
Morgan Stanley
2
Morgan Stanley
New York
$56K 79,200 +8,900 +13%
Renaissance Technologies
3
Renaissance Technologies
New York
$10K 13,700 – –
VF
4
Virtu Financial
New York
$8K 11,263 +11,263 New
UBS Group
5
UBS Group
Switzerland
$4K 6,009 +387 +7%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– – -74,081 Closed
SFM
7
Sphera Funds Management
Israel
– – -40,000 Closed
Citadel Advisors
8
Citadel Advisors
Florida
– – -32,619 Closed
OMC
9
Old Mission Capital
Illinois
– – -12,906 Closed
CFGS
10
Concourse Financial Group Securities
Alabama
– – – –